{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:28:05Z","timestamp":1791678485298,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013804","name":"Thalassemia Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017559","name":"The Garron Family Cancer Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtct.2024.12.016","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T04:29:15Z","timestamp":1735014555000},"page":"180.e1-180.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children\/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3625-2416","authenticated-orcid":false,"given":"Enass H","family":"Raffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor M","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-1162","authenticated-orcid":false,"given":"Chane","family":"Choed-Amphai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kirby-Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Odame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-1977","authenticated-orcid":false,"given":"Joerg","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin G","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-3116","authenticated-orcid":false,"given":"Soumitra","family":"Tole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-0051","authenticated-orcid":false,"given":"Jennifer","family":"Seelisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-2808","authenticated-orcid":false,"given":"Robert J","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesleigh","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9891-6759","authenticated-orcid":false,"given":"Yogi Raj","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-5536","authenticated-orcid":false,"given":"Donna A","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yueh","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.12.016_bib0001","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/bmt.2015.293","article-title":"Hematopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.12.016_bib0003","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for \u03b2-thalassemia major","volume":"117","author":"Sabloff","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.12.016_bib0004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","article-title":"A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1054\/blre.2002.0192","article-title":"The cure of thalassemia by bone marrow transplantation","volume":"16","author":"Lucarelli","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2024.12.016_bib0006","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"Sodani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.12.016_bib0007","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bbmt.2014.07.016","article-title":"Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced- toxicity conditioning regimen according to a new risk stratification","volume":"20","author":"Anurathapan","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0008","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","article-title":"Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen","volume":"26","author":"Anurathapan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0009","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2024.12.016_bib0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II Trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.12.016_bib0011","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/bloodadvances.2022008545","article-title":"Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure","volume":"7","author":"Stenger","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.12.016_bib0012","first-page":"3894","article-title":"Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease","volume":"4","author":"Ngwube","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.12.016_bib0013","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/TP.0000000000003327","article-title":"Graft-versus-host disease prophylaxis with abatacept reduces severe acute graft-versus-host disease in allogeneic hematopoietic stem cell transplant for beta-thalassemia major with busulfan, fludarabine, and thiotepa","volume":"105","author":"Khandelwal","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2024.12.016_bib0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trim.2017.07.004","article-title":"T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia","volume":"43-44","author":"Jaiswal","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jtct.2024.12.016_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2024.12.016_bib0016","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1016\/j.bbmt.2015.08.036","article-title":"Nonmyeloablative stem cell transplantation with alemtuzumab\/low- dose irradiation to cure and improve the quality of life of adults with sickle cell disease","volume":"22","author":"Saraf","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0017","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2019.02.011","article-title":"Nonmyeloablative matched sibling donor hematopoietic cell transplantation in children and adolescents with sickle cell disease","volume":"25","author":"Guilcher","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2024.12.016_bib0019","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41409-020-01065-0","article-title":"Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation","volume":"56","author":"Sugita","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41409-023-02085-2","article-title":"Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0021","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s00277-024-05883-w","article-title":"Low-dose of anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies","volume":"103","author":"Du","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2024.12.016_bib0022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-6143.2012.04342.x","article-title":"Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion","volume":"13","author":"Lo","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0023","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41409-024-02237-y","article-title":"Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model","volume":"59","author":"Kabore","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0024","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.12.016_bib0025","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0026","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/434010","article-title":"Cytokine levels in the serum of healthy subjects","volume":"2013","author":"Kleiner","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jtct.2024.12.016_bib0028","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2003-08-2708","article-title":"A critical role of CCR2\/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"103","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.12.016_bib0029","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbmt.2013.11.026","article-title":"Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children","volume":"20","author":"DiCarlo","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.12.016_bib0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/bmt.2013.216","article-title":"Conditioning regimens in allo-SCT for thalassemia major","volume":"49","author":"Mathews","year":"2014","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724008352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724008352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:39:03Z","timestamp":1772325543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724008352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666636724008352"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.12.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children\/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}